Trends in Oral and Injectable HIV Preexposure Prophylaxis Prescriptions in the US, 2013-2023
This study examines the prescribing trends of 3 oral preexposure prophylaxis medications and a long-acting injectable option from 2013 to 2023.
Authors
- Weiming Zhu (ORCID: https://orcid.org/0000-0002-9042-6202)
- Karen W. Hoover (ORCID: https://orcid.org/0000-0003-4942-7905)
- Athena P. Kourtis (ORCID: https://orcid.org/0000-0003-1585-1310)
- Robyn Neblett Fanfair (ORCID: https://orcid.org/0000-0002-9408-4254)
- Laura M. Mann (ORCID: https://orcid.org/0000-0003-1302-2711)
- Ya-Lin A. Huang (ORCID: https://orcid.org/0000-0003-3137-8594)
Institutions
- Centers for Disease Control and Prevention (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
Publication Details
- Journal
- JAMA
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1001/jama.2024.21493
- Citations
- 23
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 8.95